To determine whether SyeA orthologues in diverse Buchnera are likely to be secreted, we analysed them using BastionX and found that all 103 were predicted as T3SS effectors (Extended Data Table 1
New GLP-1 agonists beat Ozempic and Wegovy in studies And of course, generics development aside, biopharmas are creating more GLP-1 agonists that could outperform Ozempic and Wegovy
Two forces make 2026 a pivotal year for this topic
For microdosing specifically, clinical practitioners report that patients with RA who cannot tolerate or do not qualify for full-dose GLP-1 therapy are seeing meaningful reductions in morning stiffness, flare frequency, and body aches at microdose levels
In stage 5 , the eGFR is less than 15
And nausea in the morning, when your stomach is empty, can make breakfast feel like a challenge